• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Echo Therapeutics settles spat with ex-CEO Mooney

Echo Therapeutics settles spat with ex-CEO Mooney

July 7, 2015 By Brad Perriello

Echo TherapeuticsEcho Therapeutics (NSDQ:ECTE) today said it agreed to settle an ongoing dispute with former president & CEO Dr. Patrick Mooney that arose after his sudden departure in August 2013.

Mooney, a surgeon by training before he headed to the world of high finance and Wall Street, had been running things at Echo since a 2007 merger with Sontra Medical. He and his wife Elizabeth Mooney 1st sued Echo for more than $20 million in February 2014, claiming that his allegedly without-cause termination entitled him to severance benefits, defamation by Echo and its general counsel and loss of consortium, according to a regulatory filing. Echo filed a counterclaim “based upon the same conduct which provided the cause for [Mooney’s] termination,” later restructuring those claims, according to the filing.

The Mooneys sued again in July of last year, alleging wrongful use of civil proceedings and abuse of process in Echo’s original counterclaim filing, asserting another loss of consortium claim and seeking $30 million in damages.

A month later Mooney sued again, seeking to have Echo cover his legal fees from the original complaint, “many of which we had paid to date and the remainder of which were subject to a good faith dispute that counsel for our company and Dr. Mooney had been attempting to amicably resolve,” Echo said. Mooney also sought recompense for legal fees from the July action, the company said.

But today the company said it agreed to settle all the cases for a $150,000 payment to Mooney, plus unspecified additional payouts from its insurers.

Philadelphia-based Echo Therapeutics tapped board member Robert Doman for interim CEO after Mooney’s departure, replacing him in June 2014 with senior vice president, general counsel, chief compliance officer & secretary Kimberly Burke. In December 2014 Echo put former Otsuka Pharmaceuticals exec Scott Hollander in the corner office; Burke resigned later that month.

Filed Under: Legal News Tagged With: Echo Therapeutics Inc., Personnel Moves

More recent news

  • Autonomix picks up key nerve ablation catheter patent
  • Affluent Medical can move to pivotal phase of artificial urinary sphincter study
  • Globus Medical announces $500M share repurchase program
  • Cook Medical warns of issue with angiographic catheter
  • Virtuoso Surgical reports first cases with robotic endoscopy system, plans FDA IDE submission

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy